Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00616759 · ClinicalTrials.gov registry record · NA
The Effect on Cognition of Terminating ECT Induced Seizures With Propofol
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00616759 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 20 participants.
The verdict
NCT00616759, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Participating subjects are those who are referred for electroconvulsive therapy (ECT) for severe depression who have agreed to the protocol. The control group receives ECT as usual. The other group receives propofol to terminate the ECT-induced seizure timed so that the seizure lasts at least 25 seconds. Extensive neuropsychological testing is being done on both groups before beginning ECT and within 48 hours after the 6th treatment. Multiple markers of the rapidity of recovery from anesthesia are being obtained from all subjects for 6 ECTs.
Interventions
- DRUG propofol
- PROCEDURE electroconvulsive therapy
- PROCEDURE electroconvulsive therapy plus propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-09 |
| Est. Completion | 2010-03-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00616759
The ClinicalTrials.gov registry entry for NCT00616759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which propofol is the first listed.
NCT00616759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00616759 about?
NCT00616759 is a clinical study titled "The Effect on Cognition of Terminating ECT Induced Seizures With Propofol". Participating subjects are those who are referred for electroconvulsive therapy (ECT) for severe depression who have agreed to the protocol. The control group receives ECT as usual. The other group receives propofol to terminate the ECT-induced seizure timed so that the seizure lasts at least 25 sec...
What is the current status of trial NCT00616759?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2006-09. Estimated completion is 2010-03-24.
What interventions are being tested in trial NCT00616759?
The interventions under investigation include: propofol (DRUG), electroconvulsive therapy (PROCEDURE), electroconvulsive therapy plus propofol (PROCEDURE).
Who is sponsoring clinical trial NCT00616759?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.